US Broker Ratings

Bicara Therapeutics Inc. (BCAX)

⚠️ No article content returned.

..

Evolus, Inc. (EOLS) Stock Analysis: Exploring a 243.92% Potential Upside in the Healthcare Sector

Evolus, Inc. (NASDAQ: EOLS), a key player in the healthcare sector specializing in specialty and generic drug manufacturing, has garnered significant attention from investors due to its promising potential upside...

Fulgent Genetics, Inc. (FLGT) Investor Outlook: Capitalizing on a 41.99% Potential Upside

Fulgent Genetics, Inc. (FLGT) is making waves in the healthcare sector, specifically within the Diagnostics & Research industry. With a market capitalization of approximately $732.93 million, this U.S.-based company is..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: A 96.94% Potential Upside That Investors Can’t Ignore

Trevi Therapeutics, Inc. (NASDAQ: TRVI), a clinical-stage biopharmaceutical company, is garnering significant attention from investors with an impressive potential upside of nearly 97%. Specializing in the healthcare sector, particularly biotechnology,..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: Potential 86.63% Upside in CNS Therapies

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical powerhouse, is attracting significant attention from investors due to its promising pipeline of therapies targeting central nervous system (CNS) disorders. The..

InMode Ltd. (INMD) Stock Analysis: A Look at Growth Potential Amidst Healthcare Innovation

InMode Ltd. (NASDAQ: INMD), a prominent player in the healthcare sector with a specialization in medical devices, is making waves with its innovative portfolio of minimally invasive aesthetic medical products...

Immatics N.V. (IMTX) Stock Analysis: A Biotech Gem with 123% Potential Upside

Immatics N.V. (NASDAQ: IMTX), a Germany-based biotechnology company, is gaining significant attention in the healthcare sector for its pioneering work in T cell redirecting immunotherapies. With a market capitalization of..

Immunome, Inc. (IMNM) Investor Outlook: A Promising 43.75% Potential Upside in the Biotech Arena

Immunome, Inc. (NASDAQ: IMNM), a trailblazer in the biotechnology sector, is capturing the attention of investors with its innovative approach to cancer therapy. Based in Bothell, Washington, Immunome stands out..

Intellia Therapeutics (NTLA) Stock Analysis: Exploring a 115% Potential Upside in Cutting-Edge Gene Editing

Intellia Therapeutics, Inc. (NASDAQ: NTLA) is making waves in the biotechnology sector with its pioneering approach to genome editing. As a clinical-stage company, Intellia is strategically positioned in the healthcare..

Xeris Biopharma Holdings, Inc. (XERS) Stock Analysis: Exploring a 61% Potential Upside

For investors on the lookout for compelling opportunities in the biotechnology sector, Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) presents a notable case. This commercial-stage biopharmaceutical company, headquartered in Chicago, Illinois,..

CureVac N.V. (CVAC) Investor Outlook: A Closer Look at Its mRNA Ambitions and Market Position

As the biotechnology sector continues to captivate investor attention, CureVac N.V. (NASDAQ: CVAC) stands out with its strategic focus on mRNA technology—a domain that has gained significant traction in recent..

Syndax Pharmaceuticals (SNDX) Stock Analysis: A 93% Upside Potential Sparks Investor Interest

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a prominent player in the biotechnology sector, is capturing the attention of investors with its compelling growth story and substantial upside potential. With a market..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Navigating a 33% Revenue Surge and Strategic Growth Potential

Phibro Animal Health Corporation (NASDAQ: PAHC) stands out in the healthcare sector, specifically within the dynamic niche of drug manufacturing for specialty and generic animal health products. With a market..

CareDx, Inc. (CDNA) Stock Analysis: Navigating a 19.89% Potential Upside in the Healthcare Sector

CareDx, Inc. (NASDAQ: CDNA), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, is attracting attention from investors due to its robust performance metrics and..

Workday, Inc. (WDAY) Stock Analysis: Unpacking the 58.78% Potential Upside for Investors

Workday, Inc. (NASDAQ: WDAY), a prominent player in the technology sector, specifically within the software application industry, has caught the attention of investors with a current market cap of $45.43..

Diebold Nixdorf (DBD) Stock Analysis: Exploring a 14% Potential Upside

Diebold Nixdorf Incorporated (NYSE: DBD) is capturing investor attention with its promising prospects in the technology sector. Specializing in automating and transforming banking and retail experiences worldwide, the company operates..

SAP SE (SAP) Stock Analysis: Exploring a Potential 53% Upside for Investors

SAP SE (NYSE: SAP), a cornerstone in the technology sector, is making waves with its impressive market presence and strategic innovations. The German-based software giant, with a market capitalization of..

Autodesk, Inc. (ADSK) Investor Outlook: Unpacking a 49% Potential Upside Amidst Robust Growth

For investors looking to capitalize on the burgeoning technology sector, Autodesk, Inc. (NASDAQ: ADSK) presents a tantalizing opportunity. With a market capitalization of $51.85 billion, this software application titan is..

PAR Technology Corporation (PAR) Stock Analysis: Exploring a Potential Upside of Over 150%

PAR Technology Corporation (NYSE: PAR), a prominent player in the technology sector, specializes in delivering omnichannel cloud-based hardware and software solutions. With a market capitalization nearing $957 million, this U.S.-based..

Paylocity Holding Corporation (PCTY) Stock Analysis: A 50.82% Upside Potential in the Booming HCM Software Market

As investors seek opportunities in the burgeoning technology sector, Paylocity Holding Corporation (NASDAQ: PCTY) presents a compelling case for potential growth. Specializing in cloud-based human capital management (HCM) and payroll..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds